glp-1 weight loss doctor beaufort Service in Charleston, South Carolina — Charleston Healthspan Institute Tirzepatide & Semaglutide Weight Loss

The SURMOUNT-5 clinical trial published in The New England Journal of Medicine showed that Zepbound (tirzepatide) achieved an average weight loss of 20.2% compared to 13.7% with Wegovy (semaglutide) at 72 weeks

Systemic inflammation driven by steatosis and necro-inflammatory changes in MASLD activates pathways such as toll-like receptors (TLR) and Nuclear Factor-kappa B (NF-B), causing cardiac and vascular tissue damage

4.8 Avg Rating 183 total reviews 100% 4+ Stars of top 10 8 Accept Insurance confirmed of 10 5 Offer Telehealth confirmed of 10 Our rankings are based on a weighted scoring system that considers multiple factors

For questions about prescribing, dosages, side effects, or medication availability, contact your chosen pharmacy directly